Digital Pathology Diagnostic Tools - Today and Tomorrow
Date and time
Location
Wyndham Grand Pittsburgh Downtown, Grand Ballroom I
Pathology Informatics Summit 600 Commonwealth Place Pittsburgh, PA 15222Description
Field of digital pathology is developing fast, with many groups investing to develop algorithms for use in diagnosing cancer. At Roche, we use machine learning and other techniques in solving image analysis problems today, and have invested in developing algorithms to enable quantitation and advanced tissue analytics through the use of digital images.
This talk will review current clinical applications in digital pathology, and also how image analysis algorithms can provide medical value using brightfield or fluorescent applications. The total solution from staining to analysis is critical to ensure the success of algorithm applications. Further trends in image analysis will be discussed.
Who should attend? Attendees interested in...
- Current and future applications using digital pathology
- Active multiplex research projects
- Considerations for future clinical applications
Limited seats available, so reserve your spot today.
Photo: The VENTANA DP 200 slide scanner is for research use only. Not for use in diagnostic procedures.
Organized by
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. In 2015, the Roche Group employed more than 91,700 people, invested CHF 9.3 billion in R&D and posted sales of CHF 48.1 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.